Ted W. Love
2019
In 2019, Ted W. Love earned a total compensation of $10.1M as President, Chief Executive Officer and Director at Global Blood Therapeutics, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $540,000 |
|---|---|
| Option Awards | $4,595,717 |
| Salary | $596,876 |
| Stock Awards | $4,359,600 |
| Other | $5,000 |
| Total | $10,097,193 |
Love received $4.6M in option awards, accounting for 46% of the total pay in 2019.
Love also received $540K in non-equity incentive plan, $596.9K in salary, $4.4M in stock awards and $5K in other compensation.
Rankings
In 2019, Ted W. Love's compensation ranked 739th out of 13,971 executives tracked by ExecPay. In other words, Love earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 739 out of 13,971 | 95th |
Division Manufacturing | 259 out of 5,695 | 96th |
Major group Chemicals And Allied Products | 68 out of 2,194 | 97th |
Industry group Drugs | 57 out of 1,880 | 97th |
Industry Pharmaceutical Preparations | 46 out of 1,392 | 97th |
Source: SEC filing on April 28, 2021.
Love's colleagues
We found four more compensation records of executives who worked with Ted W. Love at Global Blood Therapeutics in 2019.